TCG Crossover Management »

Ocular Therapeutix shares owned by TCG Crossover Management

Quarter-by-quarter ownership of Ocular Therapeutix (OCUL) shares owned by TCG Crossover Management from 13F filings

Historical chart of TCG Crossover Management investment in Ocular Therapeutix

Tip: Access up to 7 years of quarterly data

All positions including Ocular Therapeutix held by TCG Crossover Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ocular Therapeutix by TCG Crossover Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $36M 5.3M 6.84
2024-03-31 $48M 5.3M 9.10

More positions owned by TCG Crossover Management

Cg Oncology Comm (CGON)
Dyne Therapeutics Comm (DYN)
Abivax SA Adrs (ABVX)
Silence Therapeutics Adrs (SLN)
Cogent Biosciences Comm (COGT)
Savara Comm (SVRA)
Madrigal Pharmaceuticals Comm (MDGL)
Edgewise Therapeutics Comm (EWTX)
Keros Therapeutics Comm (KROS)
Mineralys Therapeutics Comm (MLYS)
Ocular Therapeutix Comm (OCUL)
Tyra Biosciences Comm (TYRA)
Kura Oncology Comm (KURA)
Structure Therapeutics Adrs (GPCR)
Centessa Pharmaceuticals Comm (CNTA)

View all positions for TCG Crossover Management

Top funds holding Ocular Therapeutix

Summer Road
VR Adviser
Deep Track Capital
BlackRock
BlackRock
Vanguard Group
TCG Crossover Management
Logos Global Management
Opaleye Management
Citadel Advisors
State Street Corporation
Perceptive Advisors
Geode Capital Management
Assenagon Asset Management
Deltec Asset Management

View all funds holding Ocular Therapeutix